Synapse - Find an Expert

1369 Results

Immunogenicity of the live attenuated varicella vaccine following allogeneneic HCT

Meeting Abstract

Small, T. N.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Scaradavou, A.; Kobos, R.; Abendroth, H.; Casson, A.; Torok-Castanza, J.; Copeland, C.; more...
Blood (2009)

Fulltext@MSK | Save

Adjuvant bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic light-chain amyloidosis (AL): A phase II study

Meeting Abstract

Landau, H.; Hassoun, H.; Cohen, A. D.; Lesokhin, A.; Bello, C.; Hoover, E.; Riedel, E. R.; Ciminiello, J.; McCullagh, E.; Nimer, S. D.; more...
Blood (2009)

Fulltext@MSK | Save

ONS PEP resource: Anorexia

Book Section

Adams, L. A.; Cunningham, R. S.; Caruso, R. A.; Norling, M. J.; Shepard, N.; Belansky, H.
In Eaton, L. H.; Tipton, J. M. (Eds.) Putting Evidence into Practice: Improving Oncology Patient Outcomes (2009)

Fulltext@MSK | Save

US reforms can put things right

Journal Article

Euesden, A.
Cancer Nursing Practice (2009)

Fulltext@MSK | Save

Customer care

Journal Article

Euesden, A.
Cancer Nursing Practice (2009)

Fulltext@MSK | Save

Clinicopathologic evaluation of papillary carcinoma of the breast

Meeting Abstract

Wynveen, C.; Akram, M.; Brzostowski, E.; Nehhozina, T.; Goldberg, J.; Rudloff, U.; Van Zee, K.; Norton, L.; Brogi, E.
Laboratory Investigation (2009)

Fulltext@MSK | Save

Viral infections are the greatest cause of infectious mortality after cord blood (CB) transplantation (Cbt) but the mortality risk is limited to the first 4 months

Meeting Abstract

Sauter, C.; Abboud, M.; Hawke, R. M.; Heller, G.; Scaradavou, A.; Barker, F. N.
Biology of Blood and Marrow Transplantation (2009)

Fulltext@MSK | Save

Phase II study of temozolomide for relapsed sensitive or refractory small cell lung cancer

Meeting Abstract

Pietanza, M. C.; Pereira, L.; Dunne, M.; Travis, W. D.; Chan, T. A.; Ginsberg, M. S.; Holodny, A.; Kris, M. G.; Krug, L. M.
Journal of Thoracic Oncology (2009)

Fulltext@MSK | Save

Pre-engraftment syndrome (PES): A clinical syndrome after cord blood (CB) transplantation not associated with acute graft-versus-host disease (aGvHD) or transplant-related mortality (TRM)